These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9243361)
1. CD44 variant expression in cutaneous T-cell lymphoma. Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361 [TBL] [Abstract][Full Text] [Related]
2. The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma. Yamaguchi M; Morizane S; Hamada T; Miyake T; Sugaya M; Iwata H; Fujii K; Haramoto-Shiratsuki R; Nakagawa Y; Miura M; Ohshima K; Morishita K; Takahashi T; Imada M; Okada K; Uehara J; Sowa-Osako J; Iwatsuki K J Dermatol; 2019 Nov; 46(11):967-977. PubMed ID: 31515833 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome. Nguyen GH; Olson LC; Magro CM Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor. Tobisawa S; Honma M; Ishida-Yamamoto A; Saijo Y; Iizuka H J Dermatol Sci; 2013 Sep; 71(3):160-6. PubMed ID: 23702390 [TBL] [Abstract][Full Text] [Related]
5. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer. Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795 [TBL] [Abstract][Full Text] [Related]
6. CD44 expression in melanocytic lesions: a marker of malignant progression? Harwood CA; Green MA; Cook MG Br J Dermatol; 1996 Dec; 135(6):876-82. PubMed ID: 8977706 [TBL] [Abstract][Full Text] [Related]
7. BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339 [TBL] [Abstract][Full Text] [Related]
8. CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas. Dommann SN; Ziegler T; Dommann-Schener CC; Meyer J; Panizzon R; Burg G J Cutan Pathol; 1995 Oct; 22(5):407-12. PubMed ID: 8594072 [TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
10. TOX expression in different subtypes of cutaneous lymphoma. Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799 [TBL] [Abstract][Full Text] [Related]
11. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
12. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma. Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654 [TBL] [Abstract][Full Text] [Related]
13. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
14. CD44 variant exon epitopes in primary breast cancer and length of survival. Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 splice variants in human skin and epidermal tumours. Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968 [TBL] [Abstract][Full Text] [Related]
16. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas. Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025 [TBL] [Abstract][Full Text] [Related]
17. p53 immunoreactivity is uncommon in primary cutaneous lymphoma. McGregor JM; Dublin EA; Levison DA; MacDonald DM; Smith NP; Whittaker S Br J Dermatol; 1995 Mar; 132(3):353-8. PubMed ID: 7718450 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151 [TBL] [Abstract][Full Text] [Related]
19. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605 [TBL] [Abstract][Full Text] [Related]